Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555503 · ClinicalTrials.gov registry record
Registry of Mastectomy for Breast Cancer Risk Reduction
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 261
- Enrollment target
NCT00555503: Completed study, sponsored by Georgetown University.
NCT00555503 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 261 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00555503 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 261 participants
- Enrollment target
Study Summary
This is a registry for patients who have a risk-reduction mastectomy ("prophylactic mastectomy") due to being at high risk for developing breast cancer, followed by breast reconstruction. Eligible patients include those who have a breast cancer-related gene, a strong family history of breast cancer, or a personal history of high-risk conditions such as cancer in the other breast or ductal carcinoma in situ (DCIS). Patients are enrolled in the registry before surgery, and are followed for up to ten years afterwards. In addition to studying medical outcomes, we will periodically survey patients for quality-of-life issues and psychological well-being. There is no compensation for being enrolled in this registry. This registry is conducted through the Department of Plastic Surgery at Georgetown University Hospital, and is a sub-registry to the Fisher Familial Cancer Registry at the Lombardi Comprehensive Cancer Center at Georgetown University.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2007-11 |
| Est. Completion | 2014-01 |
What the finished NCT00555503 record still lists
NCT00555503 is an observational study that tracks outcomes without assigning an intervention. The registered 261 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00555503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00555503 about?
NCT00555503 is a clinical study titled "Registry of Mastectomy for Breast Cancer Risk Reduction". This is a registry for patients who have a risk-reduction mastectomy ("prophylactic mastectomy") due to being at high risk for developing breast cancer, followed by breast reconstruction. Eligible patients include those who have a breast cancer-related gene, a strong family history of breast cancer,...
What is the current status of trial NCT00555503?
This trial is currently completed. The enrollment target is 261 participants. The study started on 2007-11. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT00555503?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05124912 · 261 participants · NA
REMASTer: REcurrent Brain Metastases After SRS Trial
- NCT06559891 · 261 participants · NA
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia